Malignant melanoma of eye (disorder)
SELPAC: A Randomised three-arm, open label, Phase II study of continuous Selumetinib versus continuous or uninterrupted Selumetinib in combination with weekly Paclitaxel in Metastatic Uveal Melanoma.
Year Started: 2015
Clinical Trial Samples from SELPAC clinical trial: samples include plasma and tissue.
- Access:
- Closed to access
- Type:
- Clinical Trial
- Status:
- In progress
- Consent restrictions:
- No restrictions
| Associated Data Type | Procurement Timeframe |
|---|---|
| There is no associated data for this collection. | |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Plasma | -60°C to -85°C | N/A | Not applicable | 100% |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Plasma | -60°C to -85°C | N/A | Not applicable | 100% |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Tissue specimen | Surgical procedure (procedure) | RT | Paraffin | Not applicable | 26 - 50% |
Malignant tumor of pancreas (disorder)
Acelarate: A Phase III, open label, multicentre randomized clinical trial comparing Acelarin (NUC-1031) with Gemcitabine in patient with metastatic pancreatic carcinoma.
Year Started: 2015
Clinical Trial samples from Acelarate clinical trial. Samples include Cell Pellets, Plasma, PK-Plasma, Serum.
- Access:
- Closed to access
- Type:
- Clinical Trial
- Status:
- In progress
- Consent restrictions:
- Other animal work restriction, Xenograft restriction
| Associated Data Type | Procurement Timeframe |
|---|---|
| There is no associated data for this collection. | |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Peripheral blood mononuclear cells (PBMC) | Under -85°C | N/A | Not applicable | 100% |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Peripheral blood mononuclear cells (PBMC) | Under -85°C | N/A | Not applicable | 100% |
Malignant tumor of urinary bladder (disorder)
NEOBLADE: Phase II randomised placebo controlled Neoadjuvant chemotherapy study of Nintedanib with Gemcitabine and Cisplatin in locally advanced muscle invasive bladder cancer
Year Started: 2014
Samples from the NEOBLADE clinical trial. Samples include biopsy tissue (FFPE and frozen) and blood (processed to serum, plasma and cells).
- Access:
- Closed to access
- Type:
- Clinical Trial
- Status:
- In progress
- Consent restrictions:
- Other animal work restriction, Xenograft restriction
| Associated Data Type | Procurement Timeframe |
|---|---|
| There is no associated data for this collection. | |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Urine | -60°C to -85°C | N/A | Not applicable | 100% |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Tissue specimen | Surgical procedure (procedure) | Under -85°C | N/A | Not applicable | 51 - 75% |
Malignant tumor of breast (disorder)
CiPHER - Phase II multicentre study assessing the efficacy of Cabazitaxel in Patients with HER2-negative metastatic breast cancer and having unresectable brain metastases
Year Started: 2014
Clinical Trial samples from the CiPHER study. Samples include blood (processed to serum and plasma), urine and tissue (FFPE blocks of primary breast tumour, metastatic brain tumour and secondary cranial tissue).
- Access:
- Closed to access
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- Other animal work restriction, Xenograft restriction
| Associated Data Type | Procurement Timeframe |
|---|---|
| There is no associated data for this collection. | |
Female
Young adult (18 - 40 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Plasma | -60°C to -85°C | N/A | Not applicable | 26 - 50% | |
| Serum | -60°C to -85°C | N/A | Not applicable | 26 - 50% | |
| Urine | -60°C to -85°C | N/A | Not applicable | 26 - 50% |
Malignant melanoma of eye (disorder)
SUAVE - A randomised phase II study of sunitinib versus dacarbazine in the treatment of patients with metastatic uveal melanoma
Year Started: 2010
Clinical trial samples from the SUAVE study. Samples include bloods (serum, plasma and cell pellet).
- Access:
- Closed to access
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- Other animal work restriction, Xenograft restriction
| Associated Data Type | Procurement Timeframe |
|---|---|
| There is no associated data for this collection. | |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Plasma | -60°C to -85°C | N/A | Not applicable | 51 - 75% | |
| Serum | -60°C to -85°C | N/A | Not applicable | 51 - 75% |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Plasma | -60°C to -85°C | N/A | Not applicable | 26 - 50% | |
| Serum | -60°C to -85°C | N/A | Not applicable | 26 - 50% |